Market Overview

Brain Ischemia Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

Share:

The "2018
Brain Ischemia Drug Development Pipeline Analysis Report- Companies,
Drugs, Clinical Trials, Latest Developments in Brain Ischemia Market"

report has been added to ResearchAndMarkets.com's
offering.

Brain ischemia or Cerebral ischemia condition
refers to inadequate blood supply to the brain to enable it to cater its
regular metabolic requirements. This can result in brain tissue death,
ischemic stroke, hemorrhage, resulting in loss of movement, speech and
vision difficulties, impact on memory, weakness, unconsciousness etc.
Depending on the affected area in the brain, Brain Ischemia is
classified as focal (certain area in the brain) and global (large
portion of the brain). Analgesics, Anti- platelet drugs and BP
controlling drugs are typically administered.

To assist
researchers, investors and business development managers, the publisher
has come up with a comprehensive report on Brain Ischemia pipeline. The
report provides insights into different therapeutic candidates in
preclinical, research, discovery, NDA/IND, pre registration, phase 1,
phase 2, and phase 3 trials. Drugs under development directly and
through combination with other drugs are also included.

Current
status, developmental phase, participating companies and entities,
recent developments, orphan drug/ fast track/ other designations, drug
class are provided for each Brain Ischemia pipeline product. Mechanism
of Action and the target area of the pipeline product are also provided.
Further, clinical and preclinical trials along with results of the
trials are also included in the report.

In addition to
complete details of each product, the report provides key trends in
Brain Ischemia pipeline studies. The products under development are
categorized according to their development phase, mechanism and company
to provide detailed insights into the type of drugs being developed and
the stages of development.

Companies Mentioned

  • Aranda Pharma Ltd
  • Aronora Inc
  • CohBar Inc
  • Lixte Biotechnology Holdings
  • NeuroNascent Inc
  • NeurOp Inc
  • NoNO Inc
  • Prolong Pharmaceuticals, LLC
  • Vect-Horus SAS

Key Topics Covered:

1 Table of Contents

2
Brain Ischemia Pipeline Analysis

3 Brain Ischemia- Company
Wise Pipeline Analysis

4 Brain Ischemia R&D Pipeline Snapshots

5
Recent Developments in Brain Ischemia Pipeline

6 Appendix

For
more information about this report visit https://www.researchandmarkets.com/research/ddjkwk/brain_ischemia?w=4

View Comments and Join the Discussion!